Hansoh Biomedical R&d Company

This early-stage study tests two experimental drugs together in men with advanced prostate cancer that has stopped responding to standard hormone therapy. The drugs work by targeting proteins on cancer cells and blocking male hormones that fuel tumor growth. The main goal is to f…

This early-stage trial tests a drug called HS-20093 in 40 adults with advanced stomach or gastroesophageal junction cancer that has not responded to standard treatments. The drug is designed to attach to a protein on cancer cells and deliver a toxic payload directly to them. The …

This early-stage study tests a new drug called HS-20122 in about 1,050 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to find the safest dose and check for side effects. This is a first-in-human trial, so the drug's effectivenes…